Biogen (BIIB) Restructuring Costs (2010 - 2026)

Biogen has reported Restructuring Costs for 13 years, with the latest figure at $165.4 million in Q2 2026.

• On a quarterly basis, Restructuring Costs rose 23728.57% year-over-year to $165.4 million in Q2 2026; TTM through Jun 2026 was $187.3 million, a 301.07% increase from a year earlier, with the FY2025 full-year figure at $48.6 million, up 60.93% from the prior year.
• Restructuring Costs was $165.4 million for Q2 2026 at Biogen, up from $7.9 million in the prior quarter.
• The five-year high for Restructuring Costs was $900.0 million in Q2 2022, with the low at -$700000.0 in Q2 2025.
• Average Restructuring Costs over 5 years is $79.5 million, with a median of $10.5 million recorded in 2023.
• The sharpest annual moves came in 2025 and 2026: Restructuring Costs sank 110.61% in 2025, then surged 23728.57% in 2026.
• Over 5 years, Restructuring Costs stood at $7.0 million in 2022, then surged by 1311.43% to $98.8 million in 2023, then plunged by 94.64% to $5.3 million in 2024, then advanced by 24.53% to $6.6 million in 2025, then jumped by 2406.06% to $165.4 million in 2026.
• The last three Restructuring Costs figures came in at $165.4 million (Q2 2026), $7.9 million (Q1 2026), and $6.6 million (Q4 2025), per Business Quant data.